Practice-changing research in cardiology

New research, presented at a major cardiology congress, is set to inform best practice in cardiovascular care, with the aim of improving outcomes and reducing mortality. The Clinical Services Journal highlights some key findings.

Novel findings were revealed in more than 3,750 abstracts and clinical cases presented by scientists, from 86 countries, at the Annual Congress of the European Society of Cardiology.

Practice-changing research was presented including new findings from major studies. Among these included the findings from STEPHFpEF, the first trial of a pharmacologic agent to specifically target obesity as a treatment strategy for heart failure with preserved ejection fraction. The study indicated that obesity is a target for therapeutic intervention in this vulnerable patient group

he results of NOAH-AFNET 6 were also presented, which showed that anticoagulants cause bleeding without preventing stroke in patients with atrial high-rate episodes (AHRE), but without electrocardiogram (ECG)-diagnosed atrial fibrillation. The results of this major trial suggest that ECG documentation of atrial fibrillation is needed before starting oral anticoagulation in patients with AHRE

Log in or register FREE to read the rest

This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text. If you don't already have an account, please register with us completely free of charge.

Latest Issues

AfPP Annual Conference 2024

University of Warwick
2nd - 3rd August 2024

The Operating Theatres North Show 2024

Etihad Stadium, Manchester
12th September 2024

The AfPP Roadshow - London

Cavendish Conference Centre, London
14th September 2024

Infection Prevention 2024

ICC Birmingham
23rd - 25th September 2024

The AfPP Roadshow - Glasgow

TBA, Glasgow
5th October 2024

CSC Autumn Study Day 2024

Crowne Plaza Birmingham NEC
14th October 2024